These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21543370)

  • 41. Proton pump inhibitor prophylaxis increases the risk of nosocomial pneumonia in patients with an intracerebral hemorrhagic stroke.
    Ran L; Khatibi NH; Qin X; Zhang JH
    Acta Neurochir Suppl; 2011; 111():435-9. PubMed ID: 21725797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.
    Zirk-Sadowski J; Masoli JA; Strain WD; Delgado J; Henley W; Hamilton W; Melzer D; Ble A
    Am J Gastroenterol; 2017 Mar; 112(3):520-523. PubMed ID: 28270664
    [No Abstract]   [Full Text] [Related]  

  • 43. [Proton pump inhibitors and infection risk].
    Palencia-Herrejón E; Sánchez B; Escobar I; Gómez-Lus ML
    Rev Esp Quimioter; 2011 Mar; 24(1):4-12. PubMed ID: 21412664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adverse effects of proton pump inhibitors.
    Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G
    Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers.
    de Vries F; van Staa TP; Leufkens HG
    Osteoporos Int; 2011 May; 22(5):1641-2. PubMed ID: 20563562
    [No Abstract]   [Full Text] [Related]  

  • 46. Acid suppressants and hip fracture: duplicate publication bias?
    Bazelier M; de Boer A; de Vries F
    Bone; 2011 Oct; 49(4):920; author reply 921. PubMed ID: 21820528
    [No Abstract]   [Full Text] [Related]  

  • 47. Acid suppressants, fracture, and statistical adjustments for body mass index, smoking status, and calcium/vitamin D intake.
    de Vries F
    Am J Gastroenterol; 2011 Nov; 106(11):2051. PubMed ID: 22056590
    [No Abstract]   [Full Text] [Related]  

  • 48. Safety of long-term PPI use.
    Med Lett Drugs Ther; 2017 Aug; 59(1527):131-133. PubMed ID: 28787743
    [No Abstract]   [Full Text] [Related]  

  • 49. Proton pump inhibitors: too much of a good thing?
    Weekes LM
    Med J Aust; 2015 May; 202(9):464. PubMed ID: 25971558
    [No Abstract]   [Full Text] [Related]  

  • 50. Proton pump inhibitor therapy and osteoporosis.
    Yang YX
    Curr Drug Saf; 2008 Sep; 3(3):204-9. PubMed ID: 18691003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of proton pump-inhibiting drugs on mineral metabolism.
    Insogna KL
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton pump inhibitor side effects and drug interactions: much ado about nothing?
    Madanick RD
    Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.
    Cat TB; Charash W; Hebert J; Marden BT; Corbett SM; Ahern J; Rebuck JA
    Ann Pharmacother; 2008 Feb; 42(2):185-91. PubMed ID: 18212256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proton Pump Inhibitors and Fractures During Growth.
    Sugiyama T
    JAMA Pediatr; 2021 Feb; 175(2):208-209. PubMed ID: 32986077
    [No Abstract]   [Full Text] [Related]  

  • 55. Proton Pump Inhibitors and Fractures During Growth-Reply.
    Wang YH; Pasternak B
    JAMA Pediatr; 2021 Feb; 175(2):209-210. PubMed ID: 32986123
    [No Abstract]   [Full Text] [Related]  

  • 56. Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study.
    Chiu HF; Huang YW; Chang CC; Yang CY
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1131-6. PubMed ID: 20872906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis.
    Lai SW; Kuo YH; Liao KF
    Ann Rheum Dis; 2020 Dec; 79(12):e156. PubMed ID: 31300456
    [No Abstract]   [Full Text] [Related]  

  • 58. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
    Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
    Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton pump inhibitors: predisposers to Alzheimer disease?
    Fallahzadeh MK; Borhani Haghighi A; Namazi MR
    J Clin Pharm Ther; 2010 Apr; 35(2):125-6. PubMed ID: 20456731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PPIs and food allergy.
    Uzunismail H; Goksel S; Cagatay P; Cengiz M
    Am J Gastroenterol; 2010 Apr; 105(4):963-4. PubMed ID: 20372148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.